Cite
HARVARD Citation
Herrstedt, J. et al. (n.d.). 1573 Amisulpride, a dopamine D2/D3-antagonist, prevents chemotherapyinduced nausea and vomiting (CINV) in patients receiving highly emetogenic cisplatin or anthracycline-cyclophosphamide regimens: A randomised, double-blind, placebo-controlled, dose-ranging trial. European journal of cancer. pp. S228-S229. [Online].